Acquisition of Exclusive Medicines from Lab.Steris Portugal for ULSASI for the Year 2026

This tender is for the acquisition of exclusive medicines from Lab.Steris Portugal specifically for the ULSASI (Unidade Local de Saúde do Alto Alentejo) for the year 2026. The procurement aims to ensure the availability of essential medications that are critical for the healthcare services provided by ULSASI. Key requirements for bidders may include the ability to supply the specified exclusive medicines in compliance with regulatory standards and timelines. Additionally, bidders should demonstrate their capacity to meet the quality assurance protocols required in the pharmaceutical sector. The location of the services is within the jurisdiction of ULSASI, which operates in the Alto Alentejo region of Portugal. This tender emphasizes the importance of reliable supply chains and adherence to health regulations, ensuring that the healthcare unit can effectively serve its patient population. Interested parties are encouraged to review the tender documents for detailed specifications and submission guidelines. This procurement is vital for maintaining the operational efficiency of healthcare services and improving patient outcomes in the region.

This is a supplies contract in the health and medical services and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 6,793.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.